Literature DB >> 4086265

Study of endocrine function in myotonic dystrophy.

A Pizzi, S Fusi, G Forti, G Marconi.   

Abstract

Endocrine function was studied in 12 patients, 7 men and 5 women, with myotonic dystrophy (MD). Growth hormone (GH) was within normal limits in all the patients and there was no response to arginine stimulation. Prolactin (PRL) was above normal in only 2 cases (one man and one woman) and the response to TRH was below normal in 2 patients and slightly above in one. The GnRH test yielded a reduced LH response in 4 of the 7 men and none at all in the 4 women in whom it was done. The FSH response was below normal in only one of the 7 men and in 3 out of 4 women. The testosterone assay after HCG stimulation was borderline high in 2 out of 6 men and below normal in one. The level of thyroid hormones (T3, T4, FTI, TSH) was normal in all patients except one, whose FTI and T4 level were below normal. In the TRH test TSH was raised in only one of the 6 patients tested. The circadian rhythm of cortisol was absent in 3 out of 10 patients and 3 out of 8 patients showed no response to ACTH stimulation. The results of the study suggest that endocrine alterations are fairly frequent in MD but that they are neither specific nor correlated with disease severity or duration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4086265     DOI: 10.1007/BF02331039

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  8 in total

1.  Evaluation of the endocrine functions in dystrophia myotonica.

Authors:  O A Henriksen; J A Sundsfjord; R Nyberg-Hansen
Journal:  Acta Neurol Scand       Date:  1978-09       Impact factor: 3.209

2.  Gonadal function in males with myotonic dystrophy.

Authors:  P Harper; R Penny; T P Foley; C J Migeon; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  Myotonia dystrophica: Studies on gonadal function using luteinizing hormone-releasing hormone (LRH).

Authors:  J Sagel; L A Distiller; J E Morley; H Isaacs; G Kay; A Van Der Walt
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

4.  Letter: Normal thyrotropin-releasing hormone response in myotonia dystrophica.

Authors:  J Sagel; L A Distiller; J E Morley; H Isaacs
Journal:  Arch Neurol       Date:  1976-07

5.  Diminished prolactin reserve with myotonic dystrophy.

Authors:  P B May; A Renny; J Bastek; W Giglio; G Schneider; N Ertel
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

6.  Thyroid abnormalities in patients with myotonic dystrophy.

Authors:  K S Steinbeck; J N Carter
Journal:  Clin Endocrinol (Oxf)       Date:  1982-11       Impact factor: 3.478

7.  Myotonic dystrophy associated with thyroid disease.

Authors:  E Rioperez; J M Botella; A Palacio; I Abaitua; J L Trueba; J R Ricoy-Campo
Journal:  J Neurol Sci       Date:  1979-11       Impact factor: 3.181

8.  Hypothalamic-pituitary-gonadal function in patients with myotonic dystrophy.

Authors:  F Febres; H Scaglia; R Lisker; J Espinosa; T Morato; M Shkurovich; G Përez-Palacios
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

  8 in total
  3 in total

1.  Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study.

Authors:  M Spaziani; A Semeraro; E Bucci; F Rossi; M Garibaldi; M A Papassifachis; C Pozza; A Anzuini; A Lenzi; G Antonini; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2019-11-30       Impact factor: 4.256

2.  Study on growth hormone and insulin secretion in myotonic dystrophy.

Authors:  J M Gómez Sáez; J M Fernández Real; M Fernández Castañer; M A Navarro Moreno; J A Martínez Matos; J Soler Ramón
Journal:  Clin Investig       Date:  1994-07

3.  Primary Hyperparathyroidism and Hyperthyroidism in a Patient with Myotonic Dystrophy: A Case Report and Review of the Literature.

Authors:  Yosra Cherif; Baha Zantour; Wafa Alaya; Olfa Berriche; Samia Younes; Mohamed Habib Sfar
Journal:  Case Rep Endocrinol       Date:  2015-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.